글로벌 파이퍼 증후군 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 파이퍼 증후군 시장

파이퍼 증후군 시장은 2021년에서 2028년까지의 예측 기간 동안 4.90%의 시장 성장을 목격할 것으로 예상됩니다. 파이퍼 증후군 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 전 세계적으로 희귀 유전 질환의 유병률이 증가함에 따라 파이퍼 증후군 시장의 성장이 가속화되고 있습니다.

파이퍼 증후군은 비정상적으로 넓고 안쪽으로 휘어진 엄지와 큰 발가락, 특정 두개골의 조기 융합(두개골 조기 융합증)과 같은 증상을 보이는 희귀 유전적 질환을 말합니다. 이는 섬유아세포 성장 인자 수용체-2(FGFR2) 및 섬유아세포 성장 인자 수용체-1(FGFR1) 유전자의 돌연변이와 관련된 상염색체 우성 질환으로 정의됩니다.

전 세계 인구 중 파이퍼 증후군을 앓고 있는 환자 수의 증가는 파이퍼 증후군 시장 성장을 견인하는 주요 요인 중 하나로 작용합니다. 사람들 사이에서 유전자 발현 변화 사례의 증가와 유전적 질환 에 대한 인식의 증가는 시장 성장을 가속화합니다. 희귀 질환을 치료하기 위한 고아 약물 에 대한 수요 증가 와 이 질환에 대한 사용 가능한 치료법을 개선하기 위한 공공 및 민간 기관의 이니셔티브 급증은 시장에 더욱 영향을 미칩니다. 또한 의료비 지출 증가, 연구 기금 급증, 연구 개발 활동 수 증가는 파이퍼 증후군 시장에 긍정적인 영향을 미칩니다. 더욱이 새로운 치료법에 대한 높은 수요는 2021년에서 2028년의 예측 기간 동안 시장 참여자에게 수익성 있는 기회를 확대합니다.

• On the other hand, the high cost associated with the treatment of Pfeiffer syndrome is expected to obstruct the market growth. Concerns regarding the side effects of the drugs are projected to challenge the Pfeiffer syndrome market in the forecast period of 2021-2028.

This Pfeiffer syndrome market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info Pfeiffer syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Pfeiffer Syndrome Market Scope and Market Size

The Pfeiffer syndrome market is segmented on the basis of type, diagnosis, treatment, mode of administration, distribution channel and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the Pfeiffer syndrome market is segmented into Pfeiffer syndrome type I, Pfeiffer syndrome type II and Pfeiffer syndrome type III.
• On the basis of diagnosis, the Pfeiffer syndrome market is segmented into clinical findings, molecular genetic testing for FGFR1 and molecular genetic testing for FGFR2.
• On the basis of treatment, the Pfeiffer syndrome market is segmented into surgery, drugs, physical therapy and others.
• On the basis of mode of administration, the Pfeiffer syndrome market is segmented into injectable, oral and others.
• On the basis of distribution channel, the Pfeiffer syndrome market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
• On the basis of end user, the Pfeiffer syndrome market is segmented into hospitals, homecare, specialty clinics and others.

Global Pfeiffer Syndrome Market Country Level Analysis

The Pfeiffer syndrome market is analyzed and market size information is provided by country, type, diagnosis, treatment, mode of administration, distribution channel and end user as referenced above.

The countries covered in the global Pfeiffer syndrome market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the Pfeiffer syndrome market due to the high awareness among people and rises in drug approvals within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 because of the region's increase in research and development activities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The Pfeiffer syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Pfeiffer Syndrome Market Share Analysis

The Pfeiffer syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related Pfeiffer syndrome market.

Pfeiffer 증후군 시장 보고서에서 다루는 주요 기업은 Biogen, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck Sharp & Dohme Corp., Novartis AG, Sanofi, Teva Pharmaceutical Industries Ltd., Orion Corporation., UCB SA, Acadia Pharmaceuticals Inc., H. Lundbeck A/S, Mitsubishi Tanabe Pharma Corporation. 등 국내 및 글로벌 기업입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-63414